English | Español

Biospace
Patient Daily | Dec 28, 2025

Kyowa Kirin may see higher demand after newborn screening list expands
Patient Daily | Dec 28, 2025

AstraZeneca’s ATR inhibitor fails to show survival benefit in late-stage lung cancer study
Patient Daily | Dec 28, 2025

Aktis Oncology files IPO after multi-month pause in biotech offerings
Patient Daily | Dec 28, 2025

Trump Administration finalizes drug price agreements with nine more pharmaceutical firms
Patient Daily | Dec 28, 2025

FDA official’s skepticism impacts Disc Medicine shares amid bitopertin review
Patient Daily | Dec 28, 2025

Analysts predict further biotech gains into 2026 amid innovation and regulatory challenges
Patient Daily | Dec 27, 2025

AstraZeneca signs $2B deal with Jacobio Pharma for KRAS inhibitor development
Patient Daily | Dec 27, 2025

Cytokinetics receives FDA approval for heart disease drug Myqorzo

Trending
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

PhRMA warns of cancer drug markups, 340B program profiteering
+ Pharmaceuticals
Patient Daily | Jan 12, 2026

Six major FDA drug decisions expected in early 2026
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Pfizer leads U.S. drugmakers in planned price increases for 2026